JC Polyomavirus: How It Destroys the Myelin Sheath and Causes Progressive Multifocal Leukoencephalopathy (PML)

By

The JC Polyomavirus (JCPyV), also known as the John Cunningham virus, is one of the most common viruses in humans. It is estimated that up to 80% of adults worldwide have been infected, usually during childhood. For the vast majority of people, the infection causes no symptoms and remains harmless throughout life.

After the initial infection, the virus enters a latent (inactive) state, residing primarily in the kidneys, bone marrow, and lymphoid tissues. A healthy immune system keeps the virus under tight control, preventing it from causing disease.

JC Polyomavirus (JCPyV) is strongly regulated by epigenetic mechanisms, particularly modifications of the histone proteins around which its DNA is wrapped. After infecting a human cell, the virus forms a small chromatin structure called a viral minichromosome, allowing it to use the host cell's epigenetic machinery to remain dormant or become reactivated. Although JCPyV exhibits some DNA epigenetic markers, its activity is controlled primarily by histone acetylation rather than DNA methylation. Changes in histone acetylation can switch viral genes on or off, enabling the virus to remain latent for decades or to reactivate when immune function is severely compromised. 

When the Virus Reactivates

Problems arise when cell-mediated immunity becomes severely weakened. This can occur in people with:

  • Advanced HIV/AIDS
  • Organ transplant recipients taking immunosuppressive medications
  • Patients receiving powerful immunomodulatory therapies for autoimmune diseases such as multiple sclerosis
  • Certain cancers or other conditions that significantly impair immune function

When immune defenses decline, the dormant virus can reactivate. The virus begins to multiply, enters the bloodstream, and eventually crosses the blood-brain barrier, allowing it to infect the central nervous system.

How the JC Virus Damages the Brain

Once inside the brain, the JC virus specifically infects oligodendrocytes, the specialized cells responsible for producing and maintaining myelin.

Myelin is the protective insulating sheath that surrounds nerve fibers, allowing electrical signals to travel rapidly and efficiently throughout the brain. An easy way to understand myelin is to imagine the insulation surrounding electrical wires. When the insulation is stripped away, electrical signals become disrupted or fail altogether.

The JC virus destroys these oligodendrocytes, leading to widespread loss of myelin—a process known as demyelination.

Progressive Multifocal Leukoencephalopathy (PML)

The most serious consequence of JC virus reactivation is Progressive Multifocal Leukoencephalopathy (PML), a rare but often devastating demyelinating disease of the brain.

As the virus destroys myelin, multiple areas of the brain's white matter develop lesions. Because these lesions can occur in different regions of the brain, neurological symptoms vary from person to person and often progress rapidly over days or weeks.

Without prompt medical intervention, PML can lead to severe disability or death.

Symptoms of PML

Symptoms depend on which areas of the brain are affected but commonly include:

  • Progressive confusion
  • Memory loss
  • Personality or behavioral changes
  • Difficulty thinking clearly
  • Vision loss
  • Loss of visual fields
  • Weakness on one side of the body
  • Loss of coordination
  • Difficulty walking
  • Speech problems
  • Paralysis

Why Confusion Occurs

The destruction of myelin disrupts communication between different regions of the brain. As normal neural networks break down, patients may develop:

  • Sudden memory impairment
  • Severe disorientation
  • Difficulty concentrating
  • Personality changes
  • Progressive cognitive decline

Why Vision Loss Occurs

PML frequently affects the parieto-occipital regions of the brain, which process visual information.

Although the eyes themselves remain healthy, damage to these visual processing centers can produce:

  • Blind spots
  • Loss of peripheral vision
  • Difficulty recognizing objects
  • Cortical blindness

This type of vision loss originates in the brain rather than in the eyes.

Diagnosis

PML is considered a medical emergency because neurological damage can progress quickly.

Brain MRI

The first diagnostic step is usually an MRI of the brain, which often reveals characteristic white matter lesions caused by demyelination.

Lumbar Puncture

Definitive laboratory confirmation requires examination of cerebrospinal fluid (CSF) obtained through a lumbar puncture (spinal tap).

The CSF is tested using an ultra-sensitive polymerase chain reaction (PCR) assay to detect JC virus DNA. Finding viral DNA in the CSF strongly supports the diagnosis of PML.

Blood Tests: Assessing Risk Rather Than Diagnosing PML

Blood testing has an important but different role.

A blood test can determine whether a person has antibodies against the JC virus, indicating previous exposure. Since most adults have been infected, a positive antibody test is common and does not diagnose PML.

Instead, physicians use the JCV Antibody Index to estimate the likelihood of developing PML in patients receiving medications associated with increased risk.

JCV Antibody IndexRisk Category    General Clinical Management
Below 0.9Low risk    Continue therapy with periodic monitoring and repeat testing.
0.9–1.5Moderate risk    Close monitoring with frequent MRI scans and repeat blood testing.
Above 1.5Higher risk    Physicians may consider switching to an alternative therapy because of increased PML risk.

Blood Tests Cannot Confirm PML

A critical limitation of blood testing is that it cannot determine whether the virus has entered the brain.

If a patient develops neurological symptoms such as confusion, weakness, or vision loss, physicians generally proceed directly to:

  • Brain MRI
  • Lumbar puncture with CSF PCR testing for JC virus DNA

These tests determine whether active infection is occurring within the central nervous system.

Treatment

Currently, there is no antiviral medication that specifically eliminates the JC virus, and no cure exists for PML.

Treatment focuses on restoring the patient's immune function so the body's own defenses can control viral replication.

Depending on the underlying cause, treatment may include:

  • Discontinuing immunosuppressive or immunomodulatory medications
  • Plasma exchange (plasmapheresis) to rapidly remove certain monoclonal antibody medications from the bloodstream
  • Initiating or optimizing antiretroviral therapy (ART) in patients with HIV/AIDS
  • Supportive neurological care and rehabilitation

Recovery depends largely on how quickly immune function can be restored and how much brain injury has already occurred.

Key Takeaways

The JC Polyomavirus is extremely common and harmless in most people because the immune system keeps it dormant. However, severe immune suppression can allow the virus to reactivate, enter the bloodstream, cross the blood-brain barrier, and infect the brain.

By destroying oligodendrocytes, the virus strips away the myelin sheath that insulates nerve fibers, disrupting communication between brain cells. This results in Progressive Multifocal Leukoencephalopathy (PML), a rapidly progressive neurological disease characterized by cognitive decline, vision loss, weakness, and paralysis.

Because there is no direct antiviral therapy, early recognition, rapid diagnosis with MRI and cerebrospinal fluid PCR testing, and restoration of immune function remain the cornerstone of treatment. Prompt medical intervention offers the best chance of limiting permanent neurological damage and improving survival.

References:

Murine model of JC virus infection https://www.youtube.com/watch?v=ZwHRDikH_Qk

JC polyomavirus: a short review of its biology, its association with progressive multifocal leukoencephalopathy, and the diagnostic value of different methods to manifest its activity or presence
https://www.researchgate.net/publication/368508829_JC_polyomavirus_a_short_review_of_its_biology_its_association_with_progressive_multifocal_leukoencephalopathy_and_the_diagnostic_value_of_different_methods_to_manifest_its_activity_or_presence

JC Polyomavirus
https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/jc-polyomavirus

Progressive Multifocal Leukoencephalopathy (PML)
https://my.clevelandclinic.org/health/diseases/6101-progressive-multifocal-leukoencephalopathy-pml

Progressive multifocal leukoencephalopathy
https://www.ninds.nih.gov/health-information/disorders/progressive-multifocal-leukoencephalopathy?utm_source=chatgpt.com

How is your patient’s immune status? Review of Progressive Multifocal Leukoencephalopathy
https://epos.myesr.org/poster/esr/ecr2024/C-14330

Cross Talk between PML and p53 during Poliovirus Infection: Implications for Antiviral Defense
https://pmc.ncbi.nlm.nih.gov/articles/PMC1563870/

JC Virus: What Is It, and How Should I Test for IT?
https://myadlm.org/cln/articles/2015/august/jc-virus

Epigenetic regulation of polyomavirus JC
https://pubmed.ncbi.nlm.nih.gov/23971673/

Epigenetic regulation of polyomavirus JC involves acetylation of specific lysine residues in NF-κB p65
https://pmc.ncbi.nlm.nih.gov/articles/PMC4575817/

© 2000-2030 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a fife year copy right.
Library of Congress Card Number: LCN 00-192742 ISBN: 0-9703195-0-9  

Comments

Post a Comment

Popular posts from this blog

Schnitzler Syndrome: A Rare Autoinflammatory Disorder

By
Schnitzler syndrome is a rare, chronic autoinflammatory disease characterized by chronic urticaria (hives), recurrent fever, joint pain, and monoclonal gammopathy (abnormal proteins in the blood). First described by Dr. Liliane Schnitzler in 1972 , this condition is often misdiagnosed, leading to years of untreated symptoms before a correct diagnosis is made. The case report, " A 58-Year-Old Woman With Urticaria, Fever, and Joint Pain " , describes a case that closely aligns with my own experience with this challenging disorder. Key Features of Schnitzler Syndrome Schnitzler syndrome presents with a characteristic set of symptoms, though not all patients experience them in the same way: Chronic Urticaria (Hives) – Persistent, non-itchy or mildly itchy red patches that do not respond to antihistamines. Monoclonal Gammopathy (IgM or IgG type) – Abnormal monoclonal immunoglobulin detected in the blood (most commonly IgM ). Recurrent Fever – Unexplained fever episodes, often...
Read more

Acute Flaccid Myelitis (AFM): Understanding the “Polio-like” Illness Affecting the Spinal Cord

By
Acute flaccid myelitis (AFM) is a rare but serious neurological disorder that primarily affects children and results in sudden weakness or paralysis in the limbs. Often referred to as a “polio-like” illness, AFM has drawn growing attention over the past decade due to its similarities with poliomyelitis and its seasonal spikes in reported cases. While AFM remains uncommon, its potential severity—and the uncertainty surrounding its causes—make it an important condition for clinicians, parents, and public health officials to understand. What Is Acute Flaccid Myelitis? AFM is a condition that affects the gray matter of the spinal cord , where it damages motor neurons responsible for muscle movement. This leads to acute, flaccid paralysis , meaning muscles become limp and weak, often without warning. The condition can progress rapidly, and in some cases, the weakness can become long-lasting or even permanent. Although its symptoms resemble those of poliovirus infection, AFM is not cau...
Read more

Dysferlin Protein: Key Roles, Genetic Locations

By
Image
The purpose of this article is to share and discuss the details of a new discovery, which is highlighted within: CRISPR-Cas9: A Breakthrough Tool to Repair the DYSF Gene The dysferlin protein plays an essential role in maintaining the integrity of muscle cell membranes, particularly in tissues that endure significant mechanical stress, such as skeletal and cardiac muscles . Encoded by the DYSF gene , dysferlin is indispensable for repairing damaged cell membranes after injury caused by muscle contraction or external forces. This article explores the main locations where dysferlin is produced, its role in muscle repair, and supportive nutritional and therapeutic strategies for individuals with dysferlin deficiency, such as those affected by dysferlinopathies (e.g., Limb-Girdle Muscular Dystrophy Type 2B or Miyoshi Myopathy). Currently, there is no definitive answer as to why the severity of dysferlin protein expression or depletion varies. Do pathogens play a role in the methylation o...
Read more

Very Long-Chain Fatty Acids (VLCFAs) X-ALD and Spinal Muscular Atrophy (SMA): Exploring the Connection

By
Image
Introduction: White Brain Matter, VLCFAs, and X-ALD X-linked Adrenoleukodystrophy (X-ALD) is a rare inherited metabolic disorder and a major cause of progressive neurodegeneration in children—sometimes referred to as “childhood dementia.” Across related conditions, prevalence can range from approximately 1 in 2,000 to 1 in 500,000 newborns. Among its forms, childhood cerebral X-ALD is the most severe, marked by rapid inflammatory demyelination in the brain and often fatal outcomes if not treated early. At the core of X-ALD is a disruption in the metabolism of Very Long-Chain Fatty Acids (VLCFAs). Normally, these fatty acids are broken down in peroxisomes—specialized structures within cells that help maintain metabolic balance. In X-ALD, a mutation in the ABCD1 gene impairs this function, causing VLCFAs to accumulate, particularly in the white matter of the brain, spinal cord, and adrenal glands. This accumulation leads to demyelination, adrenal insufficiency (Addison’s disease), an...
Read more

Toxic Skin Condition Post-mRNA COVID-19 Vaccination

By
Image
Important update: My experiences have now been formally verified following several years of dismissal. Vasculitis syndromes: the pathogenic roles of COVID-19 and related vaccinations https://link.springer.com/article/10.1186/s12985-025-03032-x  ----------------------------------------- Identifying Severe Skin Conditions Post-Vaccination Following administration of the BioNTech mRNA vaccine, a small subset of individuals may develop severe and complex reactions. These reactions are often misdiagnosed or misunderstood due to their rarity and diverse presentation. This essay examines a case characterized by severe skin conditions, systemic symptoms, and complications such as hypercalcemia and crystal formation. It highlights the need for accurate diagnosis, holistic management, and increased awareness of these rare but significant vaccine-related adverse events. Initial Symptoms and Misdiagnoses Severe symptoms began shortly after the first dose of the BioNTech vaccine, initially pres...
Read more

Is ME CFS connected to Spinal Muscular Atrophy (SMA) or Post Polio?

By
Today, I understand why Spinal Muscular Atrophy (SMA) received little attention, particularly in the mid-50s. This complex and debilitating genetic illness was poorly understood, and patients' symptoms were often minimized or even dismissed. For more information, please visit the Spinal Muscular Atrophy (SMA) page on MalaCards . Even now, many neurologists lack detailed knowledge of SMA, and comprehensive examinations mentioned in research are rarely pursued. In 2008, while investigating permanent adrenal insufficiency, an MRI ordered by my endocrinologist unexpectedly revealed Chiari Malformation II. However, surgery in 2009 brought no improvement. In 2010, a DNA test showed a genetic marker in the ACTN3 gene: https://www.malacards.org/search/results?q=ACTN3%20gene%20and%20Spinal%20Muscular%20Atrophy%20(SMA) A 2015 MRI revealed ankylosing spondylitis, multiple Tarlov cysts, stenosis at L4 and L5, spinal canal narrowing, and widespread degenerative changes. Surgery on L4 and L5 ...
Read more

Polio and Post-Polio Syndrome (PPS): Summary and Key Insights

By
Image
  Abstract To investigate the possible role of poliovirus (PV) infection in the development of Post-Polio Syndrome (PPS), researchers studied serum, cerebrospinal fluid (CSF), peripheral blood lymphocytes, and muscle tissue from 47 PPS patients. Elevated IgM antibodies against poliovirus were identified in a subset of patients, with titers reaching 1:250 compared with less than 1:50 in healthy individuals and disease controls. Using polymerase chain reaction (PCR) techniques targeting the poliovirus replicase gene, PV RNA sequences were detected in peripheral blood lymphocytes from 7 of 37 patients and in the CSF of 4 of 40 patients, while no viral sequences were detected in controls. Sequencing confirmed a 99.3% homology with poliovirus type 1. These findings suggest that some PPS patients may exhibit an ongoing immune response to poliovirus antigens. The detection of poliovirus RNA raises the possibility of persistent mutated virus or defective viral particles. However, the signi...
Read more

Cytokine Storm, Mast Cell Activation Syndrome (MCAS), Endothelial Dysfunction and microclots/thrombosis?

By
Update: New Research Builds on Previous Findings Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2832234?utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamanetworkopen&utm_content=wklyforyou&utm_term=040925&adv= Conclusions: This recent cohort study builds upon earlier work by identifying COVID-related cytokine storm (COVID-CS) through common inflammation markers and comparing it with two other cytokine storm (CS) conditions: malignancy-associated hemophagocytic lymphohistiocytosis (MN-HLH) and CAR-T–associated cytokine release syndrome (CAR-T CRS) . Among the three groups, patients treated with CAR-T therapy showed the highest survival rates , in contrast to those with COVID-CS and MN-HLH. Interestingly, the study found that CAR-T CRS and COVID-CS share similar cytokine activation pathways , suggesting a comparable immune response mechanism. In c...
Read more

The Impact of Acids on Muscular and Vascular Systems: Potential Negative Outcomes

By
This is ongoing research, and updates will be included as soon as they become available. Acids, whether from external sources (like industrial chemicals) or internal imbalances (such as metabolic disorders), can have profound effects on both the muscular and vascular systems.   Exposure to strong acids or acid imbalances in the body can disrupt cellular function, cause tissue damage, and lead to systemic health problems. This article explores how acids can negatively impact muscular and vascular health, with an emphasis on both external exposure to corrosive acids and internal acid imbalances caused by metabolic disorders or genetic conditions. Since not everyone is affected by ME/CFS or COVID, it could be beneficial to test for genetic predispositions, such as amino acids, particularly fatty acids. 1. External Acid Exposure and Its Effects on Muscular and Vascular Systems 1.1. Muscular Effects Muscle tissue is highly sensitive to changes in pH, and exposure to strong acids ca...
Read more

Introduction to Adenosine and Tachycardia

By
What is Adenosine? Adenosine is a chemical found in human cells, existing in three forms: adenosine, adenosine monophosphate (AMP), and adenosine triphosphate (ATP). Adenosine is a chemical found in the body that plays many roles, including influencing heart rate and promoting sleep and relaxation. It is also used as a medication to manage certain types of tachycardia, particularly supraventricular tachycardia. Adenosine works by slowing the heart rate through its action on the cardiac tissue. Adenosine production in the body occurs through multiple pathways: Phosphorylation of Adenine: Adenine can be directly phosphorylated to form AMP (adenosine monophosphate), which is then converted to ATP, ADP, and finally adenosine through dephosphorylation reactions. Breakdown of ATP: Adenosine is primarily formed in the body through the breakdown of ATP, which releases energy. ATP can be dephosphorylated stepwise through the action of various enzymes: ATP is first converted to ADP (adeno...
Read more